Article contents
Pharmacologic therapy with flecainide for asymptomatic Wolff–Parkinson–White syndrome in an infant with severe left ventricular dyssynchrony
Published online by Cambridge University Press: 31 May 2018
Abstract
Some asymptomatic patients with Wolff–Parkinson–White syndrome have severe left ventricular dyssynchrony and dysfunction. We describe a patient who was given a diagnosis of Wolff–Parkinson–White syndrome in infancy and had a complete response to pharmacologic therapy with flecainide. Our findings suggest that flecainide is a suitable resynchronisation therapy for such infants.
Keywords
- Type
- Brief Report
- Information
- Copyright
- © Cambridge University Press 2018
References
- 4
- Cited by